Open AccessProspects of metformin in the treatment of endometriosis
Author(s) -
Margarita S. Florova,
Maria I. Yarmolinskaya,
В. В. Потин
Publication year - 2017
Publication title -
žurnalʺ akušerstva i ženskihʺ boleznej
Language(s) - English
Resource type - Journals
eISSN - 1684-0461
pISSN - 1683-9366
DOI - 10.17816/jowd66267-76
Subject(s) - medicine , metformin , biguanide , endometriosis , drug , pregnancy , oncology , gynecology , pharmacology , insulin , biology , genetics
According to recent year studies, the classical biguanide metformin has antiproliferative, proapoptotic and anti-inflammatory effects in addition to the main hypoglycemic effect. There are clinical and experimental studies these effects in the therapy of oncological and benign hyperplastic diseases. There is no data about the clinical efficacy of metformin in the therapy of endometriosis in the domestic literature, and there were a few studies in foreign sources. There was a decrease in the severity of the pain syndrome and an increase of pregnancy rate in two clinical studies with small samples. However, future studies are needed to investigate the mechanisms of the target drug effect and to develop effective regimens for the treatment of endometriosis.